Caudatin has also displayed neuroprotection in models of Alzheimer’s disease by activating TFEB and the autophagosome-lysosomal pathway mechanism of action, while also modulating PPARα. This evidence concerns the gene TFEB and early-onset autosomal dominant Alzheimer disease.